NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Second Nature

Second Nature

Private
LondonHealthcare & Life Scienceshttps://www.secondnature.io/us

Last Round

Series B

Oct 16, 2025

Total Funding Raised

$51.3M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Second Nature is a health technology company that offers a digital program focused on sustainable weight loss and healthy habit formation through behavioral science and 1-on-1 support.

Sector

Healthcare & Life Sciences

Verticals

Telemedicine, Patient Engagement, Healthcare Analytics

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Non-AI

Keywords

weight managementdigital healthGLP-1 medicationbehavior changetelemedicineobesity treatmentweight loss appclinical prescribingdietitian supportvertical SaaSB2B2C healthcareNHS digital healthOzempic alternativeweight loss program

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Second Nature Comps

Public and private peers based on sector, stage, and business model.

Second Nature comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Second Nature Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BOct 16, 2025
Series AJan 12, 2022
Series AFeb 19, 2020
SeedJul 1, 2019
SeedAug 15, 2018
Seed
May 23, 2017

Key People

Founding team and executive leadership

Mike Gibbs

Co-founder & COO

Founding Team

Richard Bosworth

Chief Technology Officer

Executive Team

Kevin Berg

Chief Financial Officer

Executive Team

Second Nature Investors

Notable investors and investment history

Second Nature investors
InvestorRounds
Connect VenturesSeries A, Seed
StageOne VenturesSeries B, Seed, Series A
WayraSeed
500 GlobalSeed
BeringeaSeries A
UNIQA VenturesSeries A
Bethnal Green VenturesSeries A, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 16, 2026

    Secured contracts with multiple UK health bodies including Mid & South Essex and Highland.

  • Apr 1, 2026

    Commissioned by the NHS and Vitality Health.

Second Nature Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Second Nature Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Second Nature's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon
Employee Range148
Year Founded2013
Last FundingOct 16, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.